Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Friday, February 03, 2012
Lilly CEO's compensation dips as profits decline | The Indianapolis Star
John C. Lechleiter's salary, stock awards, pension value and other compensation were worth about $16.4 million, the company said in a government filing on Friday.